Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.
Saved in:
| Title: | Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease. |
|---|---|
| Authors: | Wang, Changyong (AUTHOR), Lv, Shanyu (AUTHOR), Zhao, Hongyan (AUTHOR), He, Guoguo (AUTHOR), Liang, Hongshuo (AUTHOR), Chen, Kemiao (AUTHOR), Qu, Minghai (AUTHOR), He, Yonghua (AUTHOR), Ou, Chaoyan (AUTHOR) |
| Source: | Neurological Sciences. Mar2025, Vol. 46 Issue 3, p1111-1120. 10p. |
| Subjects: | Parkinson's disease, Cerebral anoxia, Medical sciences, Iron metabolism, Iron chelates |
| Abstract: | Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by motor paralysis, tremor,and cognitive impairment. Risk factors such as brain hypoxia caused by aging and abnormal expression of HIF-1α areconsidered to be key to the development of PD, including α-synuclein accumulation and ferroptosis. However, therelationship between HIF-1α signaling and ferroptosis in PD has not been elucidated. The stable expression of HIF-1αinhibits the pathological development of PD. Aging aggravates PD pathology by promoting α-synuclein accumulationand oxidative stress. Methods: The literature on lipid peroxidation, oxidative stress, iron metabolism and other key factors in Parkinson'sdisease in recent years was reviewed through a variety of literature search channels, such as PubMed and Elsevier. Results: HIF-1α mediated ferroptosis through oxidative stress and GPX4-GSH system. HIF-1α mediates ferroptosisthrough Keap1-Nrf2-ARE, Grx3 and Grx4. HIF-1α mediates ferroptosis through iron metabolism. Conclusion: This article reviews the oxygen-dependent regulatory mechanism of HIF-1α and its role in cerebralhypoxia homeostasis. Studies in the past decade have shown that Hif-1α mediated ferroptosis is important in PD.HIF-1α has a dual role, depending on the degree of cellular hypoxia and the environment. The equilibrium complexityneeds to be explained, and the role of ferroptosis needs to be investigated. The literature shows that the stabilizationof HIF-1α with PHD inhibitors and the combination of antioxidants and iron chelators are potential therapeuticdirections. In the future, the optimal use time and dose of inhibitors should be studied to improve the efficacy. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 183073177 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Wang%2C+Changyong%22">Wang, Changyong</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lv%2C+Shanyu%22">Lv, Shanyu</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Hongyan%22">Zhao, Hongyan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Guoguo%22">He, Guoguo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Hongshuo%22">Liang, Hongshuo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Kemiao%22">Chen, Kemiao</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qu%2C+Minghai%22">Qu, Minghai</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Yonghua%22">He, Yonghua</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ou%2C+Chaoyan%22">Ou, Chaoyan</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Mar2025, Vol. 46 Issue 3, p1111-1120. 10p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Cerebral+anoxia%22">Cerebral anoxia</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+sciences%22">Medical sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Iron+metabolism%22">Iron metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22Iron+chelates%22">Iron chelates</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by motor paralysis, tremor,and cognitive impairment. Risk factors such as brain hypoxia caused by aging and abnormal expression of HIF-1α areconsidered to be key to the development of PD, including α-synuclein accumulation and ferroptosis. However, therelationship between HIF-1α signaling and ferroptosis in PD has not been elucidated. The stable expression of HIF-1αinhibits the pathological development of PD. Aging aggravates PD pathology by promoting α-synuclein accumulationand oxidative stress. Methods: The literature on lipid peroxidation, oxidative stress, iron metabolism and other key factors in Parkinson'sdisease in recent years was reviewed through a variety of literature search channels, such as PubMed and Elsevier. Results: HIF-1α mediated ferroptosis through oxidative stress and GPX4-GSH system. HIF-1α mediates ferroptosisthrough Keap1-Nrf2-ARE, Grx3 and Grx4. HIF-1α mediates ferroptosis through iron metabolism. Conclusion: This article reviews the oxygen-dependent regulatory mechanism of HIF-1α and its role in cerebralhypoxia homeostasis. Studies in the past decade have shown that Hif-1α mediated ferroptosis is important in PD.HIF-1α has a dual role, depending on the degree of cellular hypoxia and the environment. The equilibrium complexityneeds to be explained, and the role of ferroptosis needs to be investigated. The literature shows that the stabilizationof HIF-1α with PHD inhibitors and the combination of antioxidants and iron chelators are potential therapeuticdirections. In the future, the optimal use time and dose of inhibitors should be studied to improve the efficacy. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183073177 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10072-024-07832-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1111 Subjects: – SubjectFull: Parkinson's disease Type: general – SubjectFull: Cerebral anoxia Type: general – SubjectFull: Medical sciences Type: general – SubjectFull: Iron metabolism Type: general – SubjectFull: Iron chelates Type: general Titles: – TitleFull: Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang, Changyong – PersonEntity: Name: NameFull: Lv, Shanyu – PersonEntity: Name: NameFull: Zhao, Hongyan – PersonEntity: Name: NameFull: He, Guoguo – PersonEntity: Name: NameFull: Liang, Hongshuo – PersonEntity: Name: NameFull: Chen, Kemiao – PersonEntity: Name: NameFull: Qu, Minghai – PersonEntity: Name: NameFull: He, Yonghua – PersonEntity: Name: NameFull: Ou, Chaoyan IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 15901874 Numbering: – Type: volume Value: 46 – Type: issue Value: 3 Titles: – TitleFull: Neurological Sciences Type: main |
| ResultId | 1 |